Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as an anti-infective drug development company

Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.

Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics, currently being evaluated in ongoing Phase 2b SPIRITUS trial; BTA074, a Phase 2 topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor in Phase 1 development for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment in Phase 2 development for influenza A and B infections.

The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA.
Managers
NameAgeSinceTitle
Joseph M. Patti, PhD522012President, CEO & Executive Director
Russell H. Plumb MBA, CPA572012Executive Chairman
Mark P. Colonnese MBA, CPA602015Chief Financial Officer & Executive Vice President
John H. Vernachio, PhD-2014Vice President-Preclinical Development
Geoffrey F. Cox, PhD722012Independent Non-Executive Director
Anne M. VanLent682013Lead Independent Non-Executive Director
Michael R. Dougherty582013Independent Non-Executive Director
John P. Richard, MBA592013Independent Non-Executive Director
Armando Anido, MBA582015Independent Non-Executive Director
Michael W. Dunne, MD562015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,640,487 34,873,116 90.3% 0 0.0% 90.3%
Shareholders
NameEquities%
Broadfin Capital LLC 3,486,711 9.02%
East Hill Management Co. LLC 3,456,520 8.95%
Krensavage Asset Management LLC 2,708,438 7.01%
Senzar Asset Management LLC 2,034,576 5.27%
The Vanguard Group, Inc. 1,044,243 2.70%
BlackRock Fund Advisors 595,971 1.54%
Renaissance Technologies LLC 571,805 1.48%
Landon Thomas Clay 327,672 0.85%
Fidelity Management & Research Co. 300,000 0.78%
Stonepine Capital Management LLC 294,269 0.76%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
BIOTA PHARMACEUTICALS ..75
AMGEN, INC.1.92%123 816
GILEAD SCIENCES, INC.-23.06%102 749
CELGENE CORPORATION-14.19%79 659
REGENERON PHARMACEUTIC..-25.15%42 787
VERTEX PHARMACEUTICALS..-32.45%21 061
ACTELION LTD21.70%18 780
GENMAB A/S22.94%10 223
TESARO INC92.24%5 166
HUALAN BIOLOGICAL ENGI..--.--%5 161
TONGHUA DONGBAO PHARMA..-83.41%4 814
NEUROCRINE BIOSCIENCES..-11.03%4 366
INTERCEPT PHARMACEUTIC..7.28%3 962
BEIJING SL PHARMACEUTI..--.--%3 397
CHINA BIOLOGIC PRODUCT..-13.15%3 327
JUNO THERAPEUTICS INC-31.79%3 311
GW PHARMACEUTICALS PLC109.08%3 243
SAREPTA THERAPEUTICS I..58.06%3 225
PEPTIDREAM INC38.54%3 063
EXELIXIS, INC.117.73%2 828
KITE PHARMA INC-9.15%2 800
Sector Bio Therapeutic Drugs
Biota Pharmaceuticals Inc : Connections
AMV Advisors
Massachusetts Biotechnology Council
International AIDS Vaccine Initiative, Inc.
Beacon Street Advisors LLC
Phase4 Partners Ltd.
Axotect, Inc.
Altiris Therapeutics, Inc.
QUE Oncology, Inc.
Georgia Venture Partners LLC
Zygogen LLC
Shire ViroPharma, Inc.
Lakewood-Amedex, Inc.
Cempra Pharmaceuticals, Inc.
SciStem Therapeutics, Inc.
Altherx, Inc.
Iterum Pharmaceuticals LLC
Company contact information
Aviragen Therapeutics, Inc.
2500 Northwinds Parkway
Suite 100
Alpharetta, GA 30009

Phone : +1.678.221.3343
Web : www.aviragen.com
© 2016 People , Fundamentals and Ownership